Skip to content
DraconiticResearch
Search Sources API
184,937 studies31 sourcesUpdated 31 min ago
Peer-reviewedCC BY 4.0Scientific Reports

Key considerations from intrinsic properties to context-dependent performance in the preclinical evaluation of crosslinked HA dermal fillers

Abstract

Current preclinical evaluation of crosslinked hyaluronic acid (HA) dermal fillers often treats individual assays—rheology, extrusion force, cohesivity, swelling—in isolation, making it difficult to relate intrinsic network properties to context-dependent performance. In this study, five crosslinked HA gels—three commercial BDDE-crosslinked fillers (Juvéderm VOLUMA, Restylane Defyne and Ifresh) and two laboratory-model spermidine-crosslinked HA (SPDHA) gels—were characterized using a multi-assay battery covering extrusion force measurement, rheological characterization (amplitude sweeps, frequency/time sweeps, thixotropy test and flow sweep), cohesivity assessment (drop weight test and dispersion time test), and water uptake evaluation (swelling factor and hydration test). We examined how these different metrics relate to each other. Our results reveal that intrinsic network properties—such as elastic modulus (G′), crossover strain (γ c ) and swelling factor—capture different aspects of gel behavior from context-dependent performance metrics—such as extrusion force, dispersion time (reflecting resistance to hydrodynamic shear), and confined hydration (simulating post-injection spatial constraint). For example, Restylane Defyne exhibited the highest γ c among all products, indicating superior intrinsic resistance to large deformation, yet it showed the shortest dispersion time—a context-dependent outcome. Such discrepancies demonstrate that no single intrinsic parameter can reliably predict context-dependent performance. Interpreting the two sets of metrics in conjunction provides a more comprehensive understanding of each gel’s behavior, which may assist clinicians in product selection and guide future clinical investigation. However, correlations obtained in vitro cannot substitute clinical evidence; further in vivo and clinical studies are necessary to validate these relationships.

Related

  1. Preliminary Clinical Evaluation in Cross‐Sectional Imaging: A Qualitative Inquiry Into the Ethical Considerations in the Era of Artificial Intelligence
    Messiah N. K. Anudjo, Sharon Docherty, Theophilus N. Akudjedu
    Journal of Medical Radiation SciencesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Preclinical Evaluation of Bacterial Lysates in Murine Disease Models: A Systematic Review
    Diana‐Larisa Ancuța, Cristin Coman
    Immunity, inflammation and diseasePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Preclinical evaluation of a fully threaded biodegradable magnesium alloy headless compression screw for enhanced fixation in small bones
    Hiroshi Noguchi, Kotaro Hanada, Ryunosuke Watanabe +7
    Journal of orthopaedic translationPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Preclinical-Clinical Discrepancies in Immune Checkpoint Inhibitor Efficacy for Triple-Negative Breast Cancer: Disease Stage, Antibody Properties, Biomarker Alignment, and Model Limitations.
    Yuwei Zhang, Hla Paing, Jing Wang
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  5. Characterization of the Preclinical in Vitro and in Vivo Pharmacokinetic Properties of the Cyclic Oligomeric Depsipeptide Ryanodine Receptor 2 Inhibitor ent-Verticilide
    T. Q. Do, R. D. Crouch, K. Wu +5
    bioRxivPreprintCC BY-NC-NDFull textPharmacology & toxicologybioRxiv
BibTeX
@article{yu2026considerations,
  title = {{Key considerations from intrinsic properties to context-dependent performance in the preclinical evaluation of crosslinked HA dermal fillers}},
  author = {Ran Yu and Jiahua Cao and Kun Zhang},
  journal = {Scientific Reports},
  year = {2026},
  month = oct,
  doi = {10.1038/s41598-026-77274-2},
  url = {https://www.nature.com/articles/s41598-026-77274-2},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Key considerations from intrinsic properties to context-dependent performance in the preclinical evaluation of crosslinked HA dermal fillers
AU  - Ran Yu
AU  - Jiahua Cao
AU  - Kun Zhang
PY  - 2026
DA  - 2026/10/28
JO  - Scientific Reports
DO  - 10.1038/s41598-026-77274-2
UR  - https://www.nature.com/articles/s41598-026-77274-2
AB  - Current preclinical evaluation of crosslinked hyaluronic acid (HA) dermal fillers often treats individual assays—rheology, extrusion force, cohesivity, swelling—in isolation, making it difficult to relate intrinsic network properties to context-dependent performance. In this study, five crosslinked HA gels—three commercial BDDE-crosslinked fillers (Juvéderm VOLUMA, Restylane Defyne and Ifresh) and two laboratory-model spermidine-crosslinked HA (SPDHA) gels—were characterized using a multi-assay battery covering extrusion force measurement, rheological characterization (amplitude sweeps, frequency/time sweeps, thixotropy test and flow sweep), cohesivity assessment (drop weight test and dispersion time test), and water uptake evaluation (swelling factor and hydration test). We examined how these different metrics relate to each other. Our results reveal that intrinsic network properties—such as elastic modulus (G′), crossover strain (γ c ) and swelling factor—capture different aspects of gel behavior from context-dependent performance metrics—such as extrusion force, dispersion time (reflecting resistance to hydrodynamic shear), and confined hydration (simulating post-injection spatial constraint). For example, Restylane Defyne exhibited the highest γ c among all products, indicating superior intrinsic resistance to large deformation, yet it showed the shortest dispersion time—a context-dependent outcome. Such discrepancies demonstrate that no single intrinsic parameter can reliably predict context-dependent performance. Interpreting the two sets of metrics in conjunction provides a more comprehensive understanding of each gel’s behavior, which may assist clinicians in product selection and guide future clinical investigation. However, correlations obtained in vitro cannot substitute clinical evidence; further in vivo and clinical studies are necessary to validate these relationships.
SN  - 2045-2322
ER  -